Xenon Pharmaceuticals Inc (XENE)
Health Care ยท Pharmaceutical Preparations
Xenon Pharmaceuticals Inc (XENE) is listed on Nasdaq, where its shares have traded since November 5, 2014. SentiSense covers Xenon Pharmaceuticals Inc in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations. Ian Mortimer is its chief executive officer. The company reports 370 employees, and its corporate website is www.xenon-pharma.com.
About Xenon Pharmaceuticals Inc
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Latest reported results
Xenon Pharmaceuticals Inc. reported revenue of $0.00 for Q2 FY2026.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 303 institutions reported holding XENE, with 101.0 million shares worth $6.1 billion in aggregate. The largest reported holders were FMR, BlackRock and Avoro Capital Advisors. Of the 5 largest reported holders, 3 added shares, 1 reduced its position and 1 held its position unchanged during the quarter.
More on XENE
- XENE sentiment: whether news and social coverage of Xenon Pharmaceuticals Inc leans bullish or bearish, and the stories driving it.
- XENE ownership: all 303 reporting institutions, plus insider and congressional trades.
- XENE financials: revenue, net income, operating margin and free cash flow through Q2 FY2026.
SentiSense also tracks daily options readings for Xenon Pharmaceuticals Inc: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does Xenon Pharmaceuticals Inc do?
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders.
What sector is XENE in?
SentiSense classifies Xenon Pharmaceuticals Inc in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations.
Where does XENE stock trade?
Xenon Pharmaceuticals Inc (XENE) is listed on Nasdaq, where its shares have traded since November 5, 2014.
Who is the CEO of Xenon Pharmaceuticals Inc?
Ian Mortimer is the chief executive officer of Xenon Pharmaceuticals Inc.